Cellectar Biosciences Statistics
Total Valuation
CLRB has a market cap or net worth of $75.28 million. The enterprise value is $50.73 million.
Important Dates
The next estimated earnings date is Monday, November 4, 2024, before market open.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CLRB has 35.85 million shares outstanding. The number of shares has increased by 100.67% in one year.
Shares Outstanding | 35.85M |
Shares Change (YoY) | +100.67% |
Shares Change (QoQ) | +94.94% |
Owned by Insiders (%) | 3.20% |
Owned by Institutions (%) | 13.64% |
Float | 26.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 7.44 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.02.
Current Ratio | 2.54 |
Quick Ratio | 2.46 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -304.38% and return on invested capital (ROIC) is -152.45%.
Return on Equity (ROE) | -304.38% |
Return on Assets (ROA) | -91.47% |
Return on Capital (ROIC) | -152.45% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.55M |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -60,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.07% in the last 52 weeks. The beta is 0.99, so CLRB's price volatility has been similar to the market average.
Beta (5Y) | 0.99 |
52-Week Price Change | -21.07% |
50-Day Moving Average | 2.10 |
200-Day Moving Average | 2.91 |
Relative Strength Index (RSI) | 47.15 |
Average Volume (20 Days) | 211,306 |
Short Selling Information
The latest short interest is 2.20 million, so 6.15% of the outstanding shares have been sold short.
Short Interest | 2.20M |
Short Previous Month | 1.62M |
Short % of Shares Out | 6.15% |
Short % of Float | 8.42% |
Short Ratio (days to cover) | 9.23 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -42.26M |
Pretax Income | -51.04M |
Net Income | -50.98M |
EBITDA | -42.02M |
EBIT | -42.26M |
Earnings Per Share (EPS) | -$3.05 |
Full Income Statement Balance Sheet
The company has $40.03 million in cash and $548,343 in debt, giving a net cash position of $39.48 million or $1.10 per share.
Cash & Cash Equivalents | 40.03M |
Total Debt | 548,343 |
Net Cash | 39.48M |
Net Cash Per Share | $1.10 |
Equity (Book Value) | 26.17M |
Book Value Per Share | 0.27 |
Working Capital | 25.10M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$38.55 million and capital expenditures -$885,671, giving a free cash flow of -$39.44 million.
Operating Cash Flow | -38.55M |
Capital Expenditures | -885,671 |
Free Cash Flow | -39.44M |
FCF Per Share | -$1.10 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CLRB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -100.67% |
Shareholder Yield | -100.67% |
Earnings Yield | -69.72% |
FCF Yield | -53.93% |
Analyst Forecast
The average price target for CLRB is $21.00, which is 900.00% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.00 |
Price Target Difference | 900.00% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Jul 22, 2022 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |